US Patent 9856324 Human monoclonal antibodies to ganglioside GD2
Patent 9856324 was granted and assigned to Mabvax Therapeutics on January, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9856324 Human monoclonal antibodies to ganglioside GD2
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.